Dexamethasone treatment failed to demonstrate noninferiority to surgery for chronic subdural hematoma and was associated with more complications and a greater risk of later surgery, according to ...

BUFFALO, N.Y. — A dramatic, threefold reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, ...

A dramatic, threefold reduction in repeat operations in patients surgically treated for chronic subdural hematoma was achieved when the artery supplying the brain covering was blocked, according to ...

LOS ANGELES ― Previous research has led to questions concerning the value of administering the steroid dexamethasone to patients with chronic subdural hematoma before surgery. Now, a small new study ...

Research by Society of Neurolnterventional Surgery (SNIS) members found that adjunctive middle meningeal artery embolization (MMAE) for the treatment of chronic subdural hematoma (CSDH) resulted in a ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid(TM) liquid embolic agent. Squid is approved for the embolization of the ...

After a hit to the head or a fall, people, especially seniors, can develop a dangerous pooling of blood and fluid between the brain's surface and it's protective covering, the dura. These "subdural ...

LOS ANGELES — Nearly 750 years ago, a mysterious illness felled Italian theologian Thomas Aquinas before he reached his sixth decade. Now, a team of medical students and a neurosurgeon think they've ...

Please provide your email address to receive an email when new articles are posted on . Irrigation at body temperature was superior to room temperature in the evacuation of chronic subdural hematoma, ...

A subdural bleed, also called a subdural hematoma, is a type of brain bleed in which the blood pools between the skull and the brain. It is usually caused by head trauma, and the severity, effects, ...

Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid™ liquid embolic agent. Squid is approved for the embolization of the middle ...